Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Classical Hodgkin Lymphoma”

114 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 114 results

Testing effectiveness (Phase 2)Looking for participantsNCT05723055
What this trial is testing

Evaluating Combination of Nivolumab and Axatilimab in Patients With Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Utah 9
Testing effectiveness (Phase 2)Study completedNCT03114683
What this trial is testing

Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma

Who this might be right for
Relapsed/Refractory Classical Hodgkin's Lymphoma
Innovent Biologics (Suzhou) Co. Ltd. 96
Testing effectiveness (Phase 2)Study completedNCT01169636
What this trial is testing

Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma

Who this might be right for
Hodgkin's Lymphoma
M.D. Anderson Cancer Center 62
Very early researchActive Not RecruitingNCT04134325
What this trial is testing

Study of PD-1 Inhibitors After CD30.CAR T Cell Therapy in Relapsed/Refractory Hodgkin Lymphoma

Who this might be right for
Relapsed Hodgkin LymphomaRefractory Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer Center 10
Large-scale testing (Phase 3)UnknownNCT04342936
What this trial is testing

Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Jiangsu HengRui Medicine Co., Ltd. 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT04938232
What this trial is testing

Ipilimumab With or Without Nivolumab in Relapsed/Refractory cHL

Who this might be right for
Hodgkin LymphomaRelapsed Hodgkin's Disease, AdultRefractory Hodgkin Lymphoma
Dana-Farber Cancer Institute 13
Early research (Phase 1)Study completedNCT05216835
What this trial is testing

Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory Classical Hodgkin Lymphoma
AstraZeneca 45
Testing effectiveness (Phase 2)Study completedNCT01022996
What this trial is testing

Study of RAD001 in Patients With Relapsed/Refractory Hodgkin Lymphoma That Has Progressed After High-dose Chemotherapy and Autologous Stem Cell Transplant and/or After Gemcitabine- or Vinorelbine- or Vinblastine-based Treatment.

Who this might be right for
Hodgkin Lymphoma
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)UnknownNCT03800706
What this trial is testing

A Phase II Study to Evaluate the Safety and Efficacy of TQB2450 Injection in Relapsed or Refractory Classical Hodgkin's Lymphoma

Who this might be right for
Safety and Effectiveness
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 85
Testing effectiveness (Phase 2)Study completedNCT02243436
What this trial is testing

Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
CLASSICAL HODGKIN LYMPHOMA
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 67
Early research (Phase 1)Ended earlyNCT01900496
What this trial is testing

Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma

Who this might be right for
Lymphoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 6
Large-scale testing (Phase 3)UnknownNCT05244642
What this trial is testing

A Phase III Study to Evaluate the Efficacy and Safety of Penpulimab in the Relapsed and Refractory Classical Hodgkin's Lymphoma

Who this might be right for
Hodgkin Disease Lymphoma
Akeso 60
Early research (Phase 1)Study completedNCT01606878
What this trial is testing

Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

Who this might be right for
Childhood Solid NeoplasmRecurrent Childhood Anaplastic Large Cell LymphomaRecurrent Neuroblastoma
Children's Oncology Group 46
Testing effectiveness (Phase 2)Looking for participantsNCT03681561
What this trial is testing

Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Veronika Bachanova 54
Large-scale testing (Phase 3)Ended earlyNCT04486391
What this trial is testing

Tislelizumab Monotherapy Versus Salvage Chemotherapy for Relapsed/Refractory Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
BeiGene 3
Testing effectiveness (Phase 2)UnknownNCT04653649
What this trial is testing

CAR T-cells Against CD30 (HSP-CAR30) for Relapsed/ Refractory Hodgkin and T-cell Lymphoma.

Who this might be right for
Hodgkin Lymphoma, AdultT Cell Lymphoma
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 30
Testing effectiveness (Phase 2)Looking for participantsNCT04378647
What this trial is testing

BREntuximab Vedotin in SEcond LIne Therapy BEfore Transplant

Who this might be right for
Hodgkin Lymphoma, Adult
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 150
Testing effectiveness (Phase 2)Ended earlyNCT06018129
What this trial is testing

A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin LymphomaNon-Hodgkin Lymphoma
Genmab 9
Testing effectiveness (Phase 2)Looking for participantsNCT04510636
What this trial is testing

Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin LymphomaRelapsed CancerRefractory Cancer
University Health Network, Toronto 37
Not applicableUnknownNCT04776265
What this trial is testing

RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT

Who this might be right for
Hodgkin Lymphoma, AdultRelapsed Hodgkin's Disease, AdultRefractory Hodgkin Lymphoma
Grupo Argentino de Tratamiento de la Leucemia Aguda 100
Load More Results